Skip to main content
HeartCited

Nattokinase لـ Atherosclerosis

B الأدلة تدعم ذلك تجربة عشوائية واحدة على الأقل، مع نتائج متسقة في معظمها.

12-month RCT showed reduced carotid intima-media thickness progression. Fibrinolytic activity well-documented. Blood pressure reduction also demonstrated.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dnattokinase\u0026condition\u003Datherosclerosis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            B

        

        

            
الخلاصة

            
            
12-month RCT showed reduced carotid intima-media thickness progression. Fibrinolytic activity well-documented. Blood pressure reduction also demonstrated.

            
            
        

    










    

  
Key Study Findings





    

        
        

            

                
                    Review
                
                
                
                
            

            
                Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks.
            
            

                
                Dose: None
                
                
                مقابل: None
                
                
                Outcome: None
                
                
                التأثير: None
                
                
                None
                
            

            
            
المجتمع المدروس: Review of anti-atherosclerotic supplements and bleeding

            
        

        
    







    
    

        
        

            

  
Key Statistics





            


    

        
4

        
الدراسات

    

    

        
300

        
المشاركون

    

    

        
            
            ↑
            
        
        
Positive

    

    

        B

        
التقييم

    




        


        
        
        

            

  
Referenced Papers





            

                
                

                    

                        
                            Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks.
                        
                        
                            
                                Review
                            
                            
                            
                        
                    

                    

                        International journal of …
                        2025
                        
                        1 اقتباسات
                        
                    

                

                
            

        

        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
الجرعات الشائعة

                

                    
                    

                        
general:

                        
2,000 FU (fibrinolytic units)/day

                    

                    
                    

                        
cardiovascularsupport:

                        
2,000-4,000 FU/day

                    

                    
                

                
                

                    الحد الأعلى: Not formally established; up to 10,800 FU/day used in clinical trials
                

                
            

            

            
            

                
الجرعات المدروسة في الأبحاث

                

                    

                        
                            

                                الجرعة
                                المدة
                                التأثير
                                ن
                            

                        
                        
                            
                            

                                None
                                --
                                
                                    
                                    Mixed
                                    
                                
                                --
                            

                            
                        
                    

                

            

            

            
            

                أفضل وقت للتناول: On empty stomach (between meals) for optimal fibrinolytic activity
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
الآثار الجانبية المُبلّغ عنها

                    
    
                        
                        
  • 
                            ⚠
                            Generally well-tolerated
                        
    • 
                        
                        
  • 
                            ⚠
                            Increased bleeding risk (fibrinolytic activity)
                        
    • 
                        
                        
  • 
                            ⚠
                            Mild gastrointestinal discomfort
                        
    • 
                        
                        
  • 
                            ⚠
                            Bruising (rare)
                        
    • 
                        
                    

                

                

                
                

                    
التفاعلات المعروفة

                    
    
                        
                        
  • 
                            ●
                            Anticoagulants — warfarin, DOACs (additive anticoagulant effects — contraindicated)
                        
    • 
                        
                        
  • 
                            ●
                            Antiplatelet drugs (additive bleeding risk)
                        
    • 
                        
                        
  • 
                            ●
                            NSAIDs (increased bleeding risk)
                        
    • 
                        
                        
  • 
                            ●
                            Fish oil at high doses (additive anticoagulant effect)
                        
    • 
                        
                    

                

                

                
                

                    

                        الحد الأقصى المسموح به: Not formally established; up to 10,800 FU/day used in clinical trials
                    

                

                
            

            

                استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Nattokinase help with Atherosclerosis?
            
        
        

            Based on 4 studies with 300 participants, there is moderate evidence from clinical studies that Nattokinase may support Atherosclerosis management. Our evidence grade is B (Good Evidence).
        

    

    
    

        
            How much Nattokinase should I take for Atherosclerosis?
            
        
        

            Studies have used various dosages. A commonly studied range is 2,000 FU (fibrinolytic units)/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Nattokinase?
            
        
        

            Reported side effects may include Generally well-tolerated, Increased bleeding risk (fibrinolytic activity), Mild gastrointestinal discomfort, Bruising (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Nattokinase and Atherosclerosis?
            
        
        

            We rate the evidence as Grade B (Good Evidence). This rating is based on 4 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  




            

                
                
                

                
                

                    
Nattokinase لحالات أخرى

                    

                        
                        
                            High Blood Pressure (Hypertension)
                            C

                        
                        
                    

                

                
            

        

        

    


    
    






  
References

  
    
    
    
  1. 
      [1]
      Maria-Zinaida Dobre et al..
      Int J Mol Sci.
      2025.
      Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks.
      doi:10.3390/ijms262010183
      PubMed
    
    2. 
    
  















    

        إخلاء مسؤولية FDA:
        لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.